The present disclosure is generally directed to activators of lipoprotein lipase useful in the treatment of diseases and disorders modulated by said enzyme and having the Formula (I), or a pharmaceutically acceptable salt, isomer, solvate, prodrug, or tautomer thereof.
本公开涉及的是
脂蛋白脂酶激活剂,其具有公式(I)或其药学上可接受的盐、异构体、溶剂合物、前药或互变异构体,在治疗受该酶调节的疾病和疾病方面具有用途。